In Polycystic ovarian syndrome (PCOS) Women with Polycystic ovarian syndrome (PCOS) have hormonal imbalance that is responsible for irregular menstrual cycles (periods), excessive hair growth and acne. Metafolate Tablet is a combination medicine that helps in regulating hormonal imbalance as well as periods in females. It helps the body to utilise the hormone insulin and also regulates menstrual cycles. Take it as prescribed by the doctor. Do not skip any doses and follow your doctor’s instructions carefully to get maximum benefit.
It is unsafe to consume alcohol with Metafolate Tablet.
Metafolate Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Metafolate Tablet during breastfeeding is not available. Please consult your doctor.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Metafolate Tablet should be used with caution in patients with kidney disease. Dose adjustment of Metafolate Tablet may be needed. Please consult your doctor. Use of Metafolate Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Metafolate Tablet should be used with caution in patients with liver disease. Dose adjustment of Metafolate Tablet may be needed. Please consult your doctor. Metafolate Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
If you miss a dose of Metafolate Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Akumentis Healthcare Ltd || ₹14.5/tablet (25% cheaper)